TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax

Citation
L. Jia et al., TRAIL-induced apoptosis in type I leukemic cells is not enhanced by overexpression of Bax, BIOC BIOP R, 283(5), 2001, pp. 1037-1045
Citations number
41
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
283
Issue
5
Year of publication
2001
Pages
1037 - 1045
Database
ISI
SICI code
0006-291X(20010525)283:5<1037:TAITIL>2.0.ZU;2-N
Abstract
We have previously shown that Bax translocation was crucial in TNF alpha or etoposide-induced apoptosis. Overexpression of Bax sensitized chronic myel oid leukemic K562 cells to etoposide-induced apoptosis, Treatment with TNF- related apoptosis-inducing ligand (TRAIL) induces a loss of mitochondrial m embrane potential (Delta Psim), cytochrome c release from mitochondria, act ivation of caspases-8, -9, and -3, and cleavage of Bid in the K562 cell Lin e. Bax failed to sensitize K562 cells to TRAIL-induced apoptosis. TRAIL did not induce Bax expression and/or translocation from cytosol to mitochondri a in the K562 cell line. However, 100 muM Z-VAD.fmk, a pan caspase inhibito r, completely blocked TRAIL-initiated mitochondrial alterations and cleavag es of caspases and Bid. We propose that TRAIL-induced apoptosis in K562 cel ls is via Type I apoptotic signal pathway. Bax translocation is not essenti al for TRAIL-induced cytochrome c release and Delta Psim collapse in the Ty pe I cells. (C) 2001 Academic Press.